Swiss Software Stock News

Temenos AG ( VTX:TEMN ) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders...

Wondering if ABB, at a last close of CHF 77.90, still offers value after such a strong run, or if you are arriving late to the story. The share price performance has been strong, with returns of 3.2% over 7 days, 23.4% over 30 days, 27.2% year to date, 82.8% over 1 year, 156.1% over 3 years and 207.8% over 5 years. This naturally raises questions about risk and upside from here. Recent coverage has focused on ABB's position in electrification, automation and power grid technology, which ties...

Nestlé reported past first-quarter 2026 group sales of CHF 21,317 million, down from CHF 22,601 million a year earlier, while organic growth and volumes improved despite an infant formula recall and currency headwinds. At the same time, the company accelerated portfolio streamlining and cost-saving efforts, including European job cuts and potential further ice cream divestments, highlighting a sharper focus on efficiency and core categories like coffee, pet care and nutrition. We’ll now...

If you are wondering whether Amrize at around CHF44.64 is priced attractively or not, the key question is how its current share price compares with its underlying business value. Recently, the stock has been relatively steady, with a 1.1% return over the last 30 days and a 3.0% decline over the last 7 days. This may reflect shifting views on its near term prospects and risk. Recent news flow on Amrize has focused more on maintaining investor visibility than on any single transformational...

Cosmo (SWX:COPN) is back in focus after reporting 12 month Phase III results for its Clascoterone 5% topical solution in male androgenetic alopecia, highlighting long term safety, ongoing efficacy and preparation for global regulatory filings. See our latest analysis for Cosmo. The latest clinical update comes after a mixed period in the market, with a 23.6% 1 month share price return and a 16.99% 3 month decline. Meanwhile, the 1 year total shareholder return sits at 111.93%, suggesting...

As European markets experience a positive upswing, with the STOXX Europe 600 Index rising by 1.91% amid easing geopolitical tensions and steady corporate earnings, investors are increasingly looking to dividend stocks as a reliable income source. In this context, selecting dividend stocks that offer stable yields can be particularly appealing for those seeking consistent returns in an environment where economic forecasts remain cautious.

Wondering whether Lonza Group at around CHF 508 per share offers value, or if the price still looks rich? This article walks through the numbers so you can judge that for yourself. The stock has had a mixed run, with a 4.8% decline over the last week, an 8.7% gain over the last 30 days, and a 1-year return of an 8.9% decline, which may signal shifting views on both risk and opportunity. Recent coverage has focused on Lonza Group's position in the life sciences sector and how investors are...

Avolta (SWX:AVOL) is back on investors’ radars after recent share price swings, with the stock posting a 4.5% decline over the past week but a small gain over the past month. See our latest analysis for Avolta. Zooming out, Avolta’s recent 7 day share price return of negative 6.4% and 1 day drop of 4.5% come after a 1 year total shareholder return of 31.9%. This suggests momentum has cooled but longer term holders are still ahead. If you are weighing Avolta’s swings against other...

Wondering whether Nestlé at around CHF 75.36 is starting to look like value or still pricing in a premium? This article breaks down what the recent market signals might be telling you. The stock has recently seen a 5.1% decline over the last week, with a 0.7% decline over 30 days and a 1.4% decline year to date, and it is 9.5% lower over 1 year, 27.4% lower over 3 years, and 18.6% lower over 5 years. Recent coverage has focused on how this weaker share price record is shaping investor...

With the business potentially at an important milestone, we thought we'd take a closer look at Peach Property Group...

Amrize (SWX:AMRZ) has caught investor attention after a recent price move, with the share closing at CHF 46.0. This development puts the focus on how its building solutions business is currently positioned. See our latest analysis for Amrize. The recent CHF 46.0 share price sits against a 1 month share price return of 9.9% and a 3 month share price return of 9.5%. This suggests short term momentum has picked up, while year to date gains remain more modest at 3.4%. If this move has you...

Helvetia Baloise Holding AG recently reported full-year 2025 results, with net income of CHF 552.3 million and basic earnings per share of CHF 10.32, and also approved an annual dividend of CHF 7.70 per share payable on May 29, 2026. The combination of higher earnings and an increased cash return through the dividend offers fresh insight into how Helvetia Baloise is allocating capital between shareholder payouts and ongoing growth initiatives. We’ll now examine how the stronger full-year...

As European markets experience a positive momentum, with the STOXX Europe 600 Index rising by 1.91% amid favorable corporate earnings and geopolitical developments, investors are increasingly focused on identifying stocks that may be trading below their intrinsic value. In such an environment, finding undervalued stocks involves assessing companies with strong fundamentals that may have been overlooked or mispriced by the market, offering potential opportunities for long-term growth despite...

ABB recently secured a contract to supply gearless mill drive and ring-geared mill drive systems for the Eva Copper Mine Project in Queensland, Australia, aiming to boost grinding efficiency, reliability and operational flexibility for the copper concentrator. This mining technology win highlights ABB’s role in enabling the energy transition through critical-minerals projects that increasingly demand efficient, low-risk processing solutions. We’ll now examine how winning a major copper mine...

AI driven beauty launch puts Givaudan (SWX:GIVN) in focus Givaudan Active Beauty’s partnership with Haut.AI to showcase AI powered ingredient simulations at in cosmetics Global 2026 is drawing fresh attention to how the business connects scientific claims with consumer facing experiences. See our latest analysis for Givaudan. At a share price of CHF2,964.0, Givaudan has seen short term momentum pick up, with a 1 month share price return of 6.66% and 7 day gain of 5.56%. However, the 1 year...

It looks like UBS Group AG ( VTX:UBSG ) is about to go ex-dividend in the next three days. The ex-dividend date is...

As European markets rally, buoyed by a U.S.-Iran ceasefire and positive investor sentiment, the pan-European STOXX Europe 600 Index has seen a notable increase of 3.05%. In this environment of cautious optimism, dividend stocks can offer an attractive proposition for investors seeking steady income streams amidst market fluctuations.

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see...

Nestlé S.A. ( VTX:NESN ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is commonly two business...

Cosmo Pharmaceuticals N.V. reported that shareholders at its recent Ordinary AGM approved all proposals, including a €2.10 per share dividend, with the ex-dividend date set for 24 April 2026 and payment on 11 May 2026. This broad shareholder backing for both governance items and a cash distribution highlights confidence in the company’s capital allocation approach and cash-generating capacity. We’ll now examine how this newly approved €2.10 dividend and strong shareholder support feed into...

R&S Group Holding AG recently reported its full-year 2025 results, with sales rising to CHF 414.84 million and net income reaching CHF 58.1 million, both higher than the prior year. The improvement in basic earnings per share from continuing operations to CHF 1.56 highlights enhanced profitability on a per-share basis alongside the company’s broader growth. With this earnings-driven backdrop and stronger per-share profitability, we will explore how these results shape R&S Group Holding’s...

In early April 2026, Roche announced that its Elecsys Neurofilament Light Chain (NfL) blood test received CE mark approval for detecting neuroinflammation in adults with relapsing-remitting multiple sclerosis, enabling minimally invasive monitoring via its widely installed cobas instruments. This approval could materially change multiple sclerosis care pathways by shifting more frequent disease monitoring from hospital-based MRI scans to accessible, standardized blood testing. Next, we’ll...

Romande Energie Holding SA's ( VTX:REHN ) solid earnings announcement recently didn't do much to the stock price. We...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...